Anebulo Receives $1.9M Grant From NIDA For Investigational IV Treatment Of Cannabis Toxic Effects
Portfolio Pulse from Benzinga Newsdesk
Anebulo Pharmaceuticals has received a $1.9 million grant from the National Institute on Drug Abuse (NIDA) for its investigational IV treatment of cannabis toxic effects. The grant will be disbursed in two tranches, with the initial $0.9 million awarded and the remaining $1 million contingent on meeting certain milestones.
July 22, 2024 | 11:05 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Anebulo Pharmaceuticals has been awarded a $1.9 million grant from NIDA for its investigational IV treatment of cannabis toxic effects. The grant will be disbursed in two tranches, with the initial $0.9 million awarded and the remaining $1 million contingent on meeting certain milestones.
The grant from NIDA provides significant funding for Anebulo's investigational treatment, which could accelerate its development and potentially lead to future revenue streams. The initial $0.9 million is already awarded, indicating immediate financial support, while the remaining $1 million is contingent on milestones, suggesting ongoing progress and potential future funding.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100